A study has demonstrated that approximately one-fifth of patients with cancer experienced PTSD several months after diagnosis, and many of these patients continued to live with PTSD years later.
A team of scientists have bound gene editing CRISPR/Cas9 to nucleotide aptamers to selectively target and edit osteosarcoma cancer cells.
Researchers have demonstrated that breast cancer can resurface 15 years after treatment, epigenetic editing has revealed a surprising insight into early breast cancer development and two breakthrough CDK4/6-inhibitor drugs have been approved for advanced breast cancer.
Researchers at the Ludwig Institute for Cancer Research (Brussels, Belgium) have discovered a novel mechanism used by tumors to evade immunotherapies.
A team of researchers have reported T cells survive a tumor’s anoxic environment and become more effective at killing cancer cells by exploiting HIF-1a and when they have access to growth factor VEGF-A.
A new genetic test could help diagnose esophageal cancer up to 8 years before symptoms appear in individuals at a high risk of the disease.
A new study has demonstrated that women may only need three cervical screens in their lifetime if they have received the HPV vaccine.
A group of researchers have discovered that even 20 years after a diagnosis, women ER-positive breast cancer still face a substantial risk of cancer returning or spreading. The study could influence decisions about long-term therapy.
Researchers at Cancer Research UK have discovered a potential combination treatment for glioblastoma, by exploiting leaks in the blood-brain barrier.
Researchers have demonstrated for the first time, in mice, that carbon nanotubes may pose a similar carcinogenic effect as asbestos.